Literature DB >> 240136

Acute and subacute effects of neuroleptics dopamine synthesis and release in the rat striatum.

B Scatton, C Garret, L Julou.   

Abstract

The effects of acute and subacute treatments with moderate doses of thioproperazine and haloperidol on dopamine synthesis and release have been examined in rat striatal slices. Synthesis and release of dopamine were determined by measuring the rate of formation of 3H-H2O during the conversion of L3,5-3H-tyrosine into 3H-Dopa and the accumulation of newly synthesized 3H-dopamine in striatal slices and their incubating medium. Possible effects of the treatments on tyrosine striatal levels or tyrosine specific activity were also investigated. Dopamine synthesis rate was markedly accelerated 2.5 hrs after the acute injection of thioproperazine, but was equal to control levels 24 hrs later. The effects of thioproperazine and haloperidol were thus determined 2.5 and 24 hrs after an acute injection and following the last injection of a repeated daily treatment of 11 days. Dopamine synthesis and release were still markedly increased 2.5 hrs after the last injection of the subacute neuroleptic treatments when compared to controls, but these effects were less pronounced than those observed 2.5 hrs after an acute injection of either drug. Conversely, dopamine synthesis and release were significantly decreased 24 hrs after the last injection of the subacute neuroleptic treatments when compared to controls. Two hypotheses are proposed to explain the changes in dopamine synthesis induced by repeated treatments with neurolptics.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 240136     DOI: 10.1007/bf00508415

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  29 in total

1.  MODIFICATION BY DRUGS OF THE METABOLISM OF 3,4-DIHYDROXYPHENYLETHYLAMINE, NORADRENALINE AND 5-HYDROXYTRYPTAMINE IN THE BRAIN.

Authors:  R LAVERTY; D F SHARMAN
Journal:  Br J Pharmacol Chemother       Date:  1965-06

2.  Importance of nervous impulse flow for the neuroleptic induced increase in amine turnover in central dopamine neurons.

Authors:  N E Andén; H Corrodi; K Fuxe; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1971-07       Impact factor: 4.432

3.  Disposition of newly synthesized amines in cell bodies and terminals of central catechol aminergic neurons. I. Effect of amphetamine and thiorproperazine on the metabolism of CA in the caudate nucleus, the substantia nigra and the ventromedial nucleus of the hypothalamus.

Authors:  F Javoy; M Hamon; J Glowinski
Journal:  Eur J Pharmacol       Date:  1970-05       Impact factor: 4.432

4.  Effects of some psychotropic drugs on dopamine synthesis in the rat striatum.

Authors:  M J Besson; A Cheramy; J Glowinski
Journal:  J Pharmacol Exp Ther       Date:  1971-04       Impact factor: 4.030

5.  Tyrosine hydroxylation in the rat striatum in vitro and in vivo after nigral lesion and chlorpromazine treatment.

Authors:  B Fyrö; H Nybäck; G Sedvall
Journal:  Neuropharmacology       Date:  1972-07       Impact factor: 5.250

6.  The fluorometric assay of catecholamines and related compounds: improvements and extensions to the hydroxyindole technique.

Authors:  R Laverty; K M Taylor
Journal:  Anal Biochem       Date:  1968-02       Impact factor: 3.365

7.  Regional accumulation of catecholamines formed from tyrosine-14C in rat brain: effect of chlorpromazine.

Authors:  H Nybäck; G Sedvall
Journal:  Eur J Pharmacol       Date:  1969-02       Impact factor: 4.432

8.  Effects of some psychotropic drugs on tyrosine hydroxylase activity in different structures of the rat brain.

Authors:  M J Besson; A Cheramy; C Gauchy; J Musacchio
Journal:  Eur J Pharmacol       Date:  1973-05       Impact factor: 4.432

9.  Changes of kinetic constant of striatal tyrosine hydroxylase elicited by neuroleptics that impair the function of dopamine receptors.

Authors:  B Zivkovic; A Guidotti
Journal:  Brain Res       Date:  1974-10-25       Impact factor: 3.252

10.  Effects of dopaminergic receptor agonists and antagonists on the activity of the neo-striatal cholinergic system.

Authors:  P G Guyenet; A F Javory; J C Beaujouan; B J Rossier; J Glowinski
Journal:  Brain Res       Date:  1975-02-07       Impact factor: 3.252

View more
  10 in total

1.  Action of the palmitic ester of pipotiazine on dopamine metabolism in the nigro-striatal, meso-limbic and meso-cortiacal systems.

Authors:  B Scatton; A Boireau; C Garret; J Glowinski; L Julou
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-01       Impact factor: 3.000

Review 2.  Clozapine--pharmacokinetic investigations and biochemical effects in man.

Authors:  M Ackenheil
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Dopamine-receptor binding and adenylate-cyclase activity in mouse striatal tissue in the supersensitivity phase after neuroleptic treatment.

Authors:  J Hyttel
Journal:  Psychopharmacology (Berl)       Date:  1978-12-08       Impact factor: 4.530

4.  Presynaptic dopamine receptors. Development of supersensitivity following treatment with fluphenazine decanoate.

Authors:  M C Nowycky; R H Roth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-11       Impact factor: 3.000

5.  Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats.

Authors:  Taleen Der-Ghazarian; Sergios Charntikov; Fausto A Varela; Cynthia A Crawford; Sanders A McDougall
Journal:  J Neural Transm (Vienna)       Date:  2010-04-06       Impact factor: 3.575

6.  Effects of chronic administration of ondansetron (GR38032F), a selective 5-HT3 receptor antagonist, on monoamine metabolism in mesolimbic and nigrostriatal dopaminergic neurons and on striatal D2-receptor binding.

Authors:  M Koulu; J Lappalainen; J Hietala; B Sjöholm
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

7.  Homovanillic acid in caudate and pre-frontal cortex following acute and chronic neuroleptic administration.

Authors:  M B Bowers; F J Hoffman
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

8.  Supersensitivity of dopamine-autoreceptors. The effect of gammabutyrolactone in long-term haloperidol treated rats.

Authors:  G Stock; J Steinbrenner; P Kummer
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

9.  Subsensitivity of striatal and mesolimbic dopamine target cells after repeated treatment with apomorphine dipivaloyl ester.

Authors:  B Scatton; P Worms
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-07       Impact factor: 3.000

10.  Incorporation of 4.5-3-H-leucine into the limbic system of ICR mice as a long-term effect of haloperidol application.

Authors:  P Hackenberg
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.